Biotech · Private company

Biotrial

Track this companyFree. Adds Biotrial to your Dealase workspace and tells you when its record changes.

Clinical trials41 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Open-Label Extension of EryDex Study IEDAT-04-2022PHASE3 · TERMINATED · started Dec 11, 2024ClinicalTrials.gov NCT06664853 · fetched Nov 12, 2026
Evaluate the Neurological Effects of EryDex on Subjects With A-TPHASE3 · COMPLETED · started Jun 24, 2024ClinicalTrials.gov NCT06193200 · fetched Nov 12, 2026
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.PHASE1 · RECRUITING · started Oct 20, 2022ClinicalTrials.gov NCT05547321 · fetched Nov 12, 2026
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerSPHASE1 · COMPLETED · started Mar 9, 2022ClinicalTrials.gov NCT05323708 · fetched Nov 12, 2026